课题基金 / 基金详情

How Does Osteocalcin Reverse Glucocorticoid-Induced Dysmetabolism?

How Does Osteocalcin Reverse Glucocorticoid-Induced Dysmetabolism?
骨钙素如何逆转糖皮质激素引起的代谢异常?
批准号:
nhmrc : GNT1086100
负责人:
Dr Michael Swarbrick
金额:
$61.52万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 --

项目摘要

项目成果

Dr Michael Swarbrick的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The benefits of glucocorticoids (GCs) are often compromised by adverse effects such as bone loss, diabetes & obesity. There is now evidence that osteocalcin regulates fuel metabolism. Osteocalcin may therefore be a potential target to prevent the adverse metabolic effects of GC therapy. We aim to determine how osteocalcin regulates energy metabolism in adipose tissue and the liver under conditions of GC excess, and whether and how osteocalcin acts through a G-protein coupled receptor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Age-Related Changes in Body Composition and Fuel Metabolism: The Role of Glucocorticoid Signalling in Osteoblasts
  • 批准号:
    nhmrc : 1101879
  • 项目类别:
    Project Grants
  • 资助金额:
    $56.42万
  • 财政年份:
    2016
  • 负责人:
    Dr Michael Swarbrick
  • 依托单位:
Age-Related Changes in Body Composition and Fuel Metabolism: The Role of Glucocorticoid Signalling in Osteoblasts
  • 批准号:
    nhmrc : GNT1101879
  • 项目类别:
    Project Grants
  • 资助金额:
    $82.05万
  • 财政年份:
    2016
  • 负责人:
    Dr Michael Swarbrick
  • 依托单位:
How Does Osteocalcin Reverse Glucocorticoid-Induced Dysmetabolism?
  • 批准号:
    nhmrc : 1086100
  • 项目类别:
    Project Grants
  • 资助金额:
    $42.34万
  • 财政年份:
    2015
  • 负责人:
    Dr Michael Swarbrick
  • 依托单位:
海外基金